{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:34:00Z","timestamp":1791304440822,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R-995882"],"award-info":[{"award-number":["R-995882"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-1000881"],"award-info":[{"award-number":["OLL-1000881"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Stiftelsen Professor Nanna Svartz Fond","doi-asserted-by":"publisher","award":["2021-00436"],"award-info":[{"award-number":["2021-00436"]}],"id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["810316"],"award-info":[{"award-number":["810316"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005295","name":"Staedtler Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC\/TRR 305"],"award-info":[{"award-number":["CRC\/TRR 305"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115565"],"award-info":[{"award-number":["115565"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","award":["FAI-2023-1055"],"award-info":[{"award-number":["FAI-2023-1055"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-974449"],"award-info":[{"award-number":["SLS-974449"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ard.2025.06.2132","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T03:53:39Z","timestamp":1753242819000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus"],"prefix":"10.1016","volume":"85","author":[{"given":"Panagiotis","family":"Garantziotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-9471","authenticated-orcid":false,"given":"Julius","family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia-Savina","family":"Moysidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-6966","authenticated-orcid":false,"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-5135","authenticated-orcid":false,"given":"Ricardo","family":"Grieshaber-Bouyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-9171","authenticated-orcid":false,"given":"Christina","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wirsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Bozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2106-9196","authenticated-orcid":false,"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-1028","authenticated-orcid":false,"given":"Guillermo","family":"Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bertsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios T","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.06.2132_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2132_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000310","article-title":"Changing paradigms in the treatment of systemic lupus erythematosus","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0003","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.06.2132_bib0004","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/rheumatology\/keac185","article-title":"Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus","volume":"61","author":"Emamikia","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ard.2025.06.2132_bib0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard-2023-224795","article-title":"Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort","volume":"83","author":"Parodis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2132_bib0006","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2025.06.2132_bib0007","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard-2024-226051","article-title":"Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways","volume":"84","author":"Moysidou","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2025.06.2132_bib0008","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2132_bib0009","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ard.2025.06.2132_bib0010","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2025.06.2132_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179433","article-title":"Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLE","volume":"9","author":"Wilhelm","year":"2024","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2132_bib0012","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2132_bib0013","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.1780340802","article-title":"Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study","volume":"34","author":"Petri","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2132_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005050","article-title":"Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus","volume":"11","author":"Garantziotis","year":"2025","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2132_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1208\/s12248-012-9447-1","article-title":"Strategic applications of gene expression: from drug discovery\/development to bedside","volume":"15","author":"Bai","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.ard.2025.06.2132_bib0016","first-page":"159","article-title":"Interpreting personal transcriptomes: personalized mechanism-scale profiling of RNA-seq data","author":"Perez-Rathke","year":"2013","journal-title":"Pac Symp Biocomput"},{"issue":"D1","key":"10.1016\/j.ard.2025.06.2132_bib0017","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0018","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2132_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ard.2025.06.2132_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8214379","article-title":"DNA damage and deficiencies in the mechanisms of its repair: implications in the pathogenesis of systemic lupus erythematosus","volume":"2018","author":"Mireles-Canales","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.ard.2025.06.2132_bib0021","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clim.2004.04.007","article-title":"Apoptosis in systemic lupus erythematosus","volume":"112","author":"Kaplan","year":"2004","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2132_bib0022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-024-01003-y","article-title":"Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells","volume":"31","author":"Huang","year":"2024","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2132_bib0023","doi-asserted-by":"crossref","first-page":"iqad005","DOI":"10.1093\/oxfimm\/iqad005","article-title":"A cellular overview of immunometabolism in systemic lupus erythematosus","volume":"4","author":"Psarras","year":"2023","journal-title":"Oxf Open Immunol"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2132_bib0024","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2025.06.2132_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303935","article-title":"Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle","volume":"14","author":"Lickefett","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0026","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.06.2132_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2132_bib0028","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1191\/0961203304lu1009oa","article-title":"Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption","volume":"13","author":"Willeke","year":"2004","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0029","first-page":"531","article-title":"Effect of G-CSF and GM-CSF on expression of TNF-alpha mRNA and CD69 and secretion of IgG in peripheral blood mononuclear cells from systemic lupus erythematosus patients]","volume":"10","author":"Lu","year":"2002","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.ard.2025.06.2132_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000236414","article-title":"Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data","volume":"100","author":"Fishman","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"issue":"338","key":"10.1016\/j.ard.2025.06.2132_bib0031","doi-asserted-by":"crossref","first-page":"ra77","DOI":"10.1126\/scisignal.2005105","article-title":"The tyrosine kinase Lyn limits the cytokine responsiveness of plasma cells to restrict their accumulation in mice","volume":"7","author":"Infantino","year":"2014","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.ard.2025.06.2132_bib0032","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ki.2015.196","article-title":"IL-3 contributes to development of lupus nephritis in MRL\/lpr mice","volume":"88","author":"Renner","year":"2015","journal-title":"Kidney Int"},{"issue":"43","key":"10.1016\/j.ard.2025.06.2132_bib0033","doi-asserted-by":"crossref","first-page":"eabo5840","DOI":"10.1126\/sciadv.abo5840","article-title":"ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus","volume":"8","author":"Manolakou","year":"2022","journal-title":"Sci Adv"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2132_bib0034","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus","volume":"113","author":"Jury","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ard.2025.06.2132_bib0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard-2024-226142","article-title":"CD19-CAR T-cell therapy induces deep tissue depletion of B cells","volume":"84","author":"Tur","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.06.2132_bib0036","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2025.06.2132_bib0037","article-title":"Targeting type I interferons in systemic lupus erythematous","volume":"13","author":"Bruera","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0038","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ekir.2024.03.014","article-title":"Interferon and B-cell signatures inform precision medicine in lupus nephritis","volume":"9","author":"Parodis","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2132_bib0039","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:20:14Z","timestamp":1769826014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725041871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003496725041871"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2132","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}